# Lattice Inc – FDA Inspection, May 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/lattice-inc/e08fce41-a667-4e11-a410-cb26e8e09f55
Source feed: FDA_Inspections

> FDA inspection 1270487 of Lattice Inc, May 22, 2025. 7 citations under 21 CFR parts 801 and 820. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1270487
- Company Name: Lattice Inc
- Inspection Date: 2025-05-22
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Chicago District Office
- Citation Count: 7

## Related Documents

- [FDA Inspection 1117176 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/lattice-inc/a91cd6d9-c2c0-49cc-82a8-afec2f9efdf3)
- FDA Inspection 917726 - 2015-03-12
- [FDA Inspection 811199 - 2012-12-06](https://www.keypedia.com/records/fda_inspections/lattice-inc/c0642116-9815-482c-84eb-0414e0df012a)

## Related Officers

- [Investigator](https://www.keypedia.com/people/lesley-mae-p-lutao/bfdcc755-28e5-4caf-91f9-b9579df4731e)
- [FDA Personnel](https://www.keypedia.com/people/zoey-a-trombley/cb7ac4dd-bc47-4b51-8fef-a485b122c921)

Company: https://www.keypedia.com/companies/lattice-inc/300ca91e-9175-4b16-b42b-66d755e58952

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
